Table 3.
Detailed information of 16 phenols
| No | Ingredients | Diseases | Use of cell lines | Mechanism of action | References | 
|---|---|---|---|---|---|
| 1 | Gallic acid | Bladder cancer | TSGH-8301 | ↓p-ERK | Liao et al. (2018) | 
| 2 | Carvacrol | Choriocarcinoma | JAR and JEG3 | ↓p-ERK1/2,↑p-JNK and↑p–p38 | Lim et al. (2019) | 
| 3 | Hydroxychavicol | Colon cancer | HT-29 | ↑p-JNK and↑p–p38 | Rajedadram et al. (2021) | 
| 4 | Ferulic acid | Lung cancer and Liver cancer | A549 and HepG2 | ↓p–p38 | Das et al. (2019) | 
| 5 | Honokiol | Oral squamous cell carcinoma | OC2 and OCSL | ↓p-ERK, ↓p-JNK and ↓p–p38 | Huang et al. (2018) | 
| 6 | Vanillin | Colorectal cancer | SW480 and HT-29 | ↑p–p38 | Li et al. (2021a, b, c) | 
| Colon cancer | HCT-116 | ↓p-ERK, ↓p-JNK and ↓p–p38 | Li et al. (2018a, b) | ||
| 7 | Sinapic Acid | Human neuroblastoma | SH-SY6Y | ↓p-ERK1/2,↓p-JNK and ↓p–p38 | Tungalag and Yang (2021) | 
| 8 | Resveratrol | Pancreatic cancer | Panc-1 | ↓p-ERK and ↓p–p38 | Chen and Liu (2018) | 
| Gastric cancer | GC7901 | ↓RAF | Yang et al. (2018) | ||
| 9 | Chlorogenic acid | Lung cancer | A549 | ↑p38 | Yamagata et al. (2018) | 
| 10 | Gingerol | Colon cancer | HCT116 | ↑p-ERK,↑p-JNK and↑p–p38 | Chen and Liu (2018) | 
| 11 | Peperobtusin A | Lymphoma | U937 | ↑p–p38 | Shi et al. (2018) | 
| 12 | Curcumin | Retinoblastoma | RB Y79 | ↑p-JNK and↑p–p38 | Wang et al. (2021a, b) | 
| Adrenocortical carcinoma | SW-13 and NCI-H295R | ↑p-JNK and↑p–p38 | Huang et al. (2021a, b) | ||
| 13 | Rubioncolin C | Triple negative breast cancer | MDA-MB-231 | ↑p-ERK,↑p-JNK and↑p–p38 | Li et al. (2021a, b, c) | 
| 14 | Salvianolic acid A | B-cell lymphoma | Raji and Jeko-1 | ↑p-JNK, ↓p-ERK and ↓p–p38 | Li et al. (2021a, b, c) | 
| 15 | Proanthocyanidins | Lung cancer | LLC and A549 | ↑p-JNK and↑p–p38 | Xu et al. (2021) | 
| 16 | Salvianolic acid B | Osteosarcoma | MG63 | ↑p–p38 | Zeng et al. (2018a, b) |